Amy Dreher

Amy Dreher is a seasoned professional in regulatory affairs, currently serving as Senior Manager of Regulatory Affairs CMC at Alnylam Pharmaceuticals since June 2021, following a progression from Manager in the same area. Dreher has extensive experience from previous roles at Regeneron Pharmaceuticals, Inc., where responsibilities included preparing global CMC documents for various regulatory submissions as a CMC Regulatory Sciences Specialist, and conducting thorough investigations as a Process Sciences Associate. Early career experience includes a Cell Culture Lab Intern position at Nemucore Medical Innovations. Dreher holds a Bachelor of Science in Biomedical/Medical Engineering from Worcester Polytechnic Institute.